Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein Are important prognostic factors for salvage liver transplantation

Liver Transplantation

Volumn 20, Issue 9, 2014, Pages 1057-1063

  Lee, Sanghoon ^a   Kwon, Choon Hyuck David ^a   Kim, Jong Man ^a   Joh, Jae Won ^a   Paik, Seung Woon ^a   Kim, Bong Wan ^b   Wang, Hee Jung ^b   Lee, Kwang Woong ^c   Suh, Kyung Suk ^c   Lee, Suk Koo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; AFP PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; BILIARY TRACT DISEASE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CORTICOSTEROID THERAPY; FEMALE; FOLLOW UP; GRAFT SALVAGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE PERFORATION; KOREA; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT OUTCOME; ADVERSE EFFECTS; BLOOD; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIAL; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REOPERATION; RISK FACTOR; SALVAGE THERAPY; SOUTH KOREA; TIME; TUMOR RECURRENCE;

ADULT; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; REOPERATION; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84906716763     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23919     Document Type: Article

References (17)

1. Shabahang M, Franceschi D, Yamashiki N, Reddy R, Pappas PA, Aviles K, et al. Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients. Ann Surg Oncol 2002; 9: 881-886.
2. Margarit C, Escartín A, Castells L, Vargas V, Allende E, Bilbao I,. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl 2005; 11: 1242-1251.
3. Cha CH, Ruo L, Fong Y, Jarnagin WR, Shia J, Blumgart LH, DeMatteo RP,. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 2003; 238: 315-321.
4. Poon RT, Fan ST, Lo CM, Liu CL, Ng IO, Wong J,. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 2000; 18: 1094-1101.
5. Poon RT, Fan ST, Lo CM, Liu CL, Wong J,. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002; 235: 373-382.
6. Belghiti J, Cortes A, Abdalla EK, Régimbeau JM, Prakash K, Durand F, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003; 238: 885-892.
7. Majno PE, Sarasin FP, Mentha G, Hadengue A,. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 2000; 31: 899-906.
8. Poon RT,. Optimal initial treatment for early hepatocellular carcinoma in patients with preserved liver function: transplantation or resection? Ann Surg Oncol 2007; 14: 541-547.
9. Moon JI, Kwon CH, Joh JW, Choi GS, Jung GO, Kim JM, et al. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival. Transplant Proc 2012; 44: 487-493.
10. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A III, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
11. Korean Liver Cancer Study Group and National Cancer Center, Korea. Practice guidelines for management of hepatocellular carcinoma 2009 [in Korean]. Korean J Hepatol 2009; 15: 391-423.
12. Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P, et al. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003; 9: 513-520.
13. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
14. Fuks D, Dokmak S, Paradis V, Diouf M, Durand F, Belghiti J,. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology 2012; 55: 132-140.
15. Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998; 227: 80-85.
16. Minagawa M, Makuuchi M, Takayama T, Kokudo N,. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003; 238: 703-710.
17. Poon RT, Fan ST, Lo CM, Liu CL, Wong J,. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999; 229: 216-222.